Dissertation > Excellent graduate degree dissertation topics show

Relationship between Expression of Vascular Endothelial Growth Factor as Well as Epidermal Growth Factor Receptor and Chemotherapy Outcome in Non-Small Cell Lung Cancer

Author: YuBo
Tutor: WangXiuWen
School: Shandong University
Course: Oncology
Keywords: vascular endothelial growth factor epidermal growth factor receptor lung cancer immunohistochmistry
CLC: R734.2
Type: Master's thesis
Year: 2010
Downloads: 79
Quote: 0
Read: Download Dissertation

Abstract


Objective We undertook to analyze the expression of the VEGF and EGFR by immunohistochmistry in the tumor tissue from 74 patients with advanced non-small cell lung cancer. The 74 patients received chemotherapy with gemcitabine plus cisplatin and their therapeutic efficacy was evaluated after 2 cycles of chemotherapy. Then investigate the relationship between VEGF expression as well as EGFR and chemotherapy outcome in non-small cell lung cancer, thereby to investigate it’s meaning in the morbidity and progression of the disease.Methods 74 patients with NSCLC including 44 males and 30 females were all inⅢb orⅣstage and incompatible for surgery and had a definite pathological diagnosis and measurable metastases. Their karnofsky score>60, and their blood, liver, kidney function, ECG were normal.74 patients with NSCLC received chemotherapy with gemcitabine (1000 mg/m2) plus cisplatin (75 mg/m2) every 21 days as a cycle. The therapeutic efficacy was evaluated after 2 cycles of chemotherapy. Expression of VEGF and EGFR in tissue samples from NSCLC were investigated with immunohistochmistry.Therapeutic efficacy was in accordance with RECIST (response evaluation criteria in solid tumor), including complete response (CR), partial response (PR), stable disease (SD), progressive disease (PD). The effective rate was referred to (CR+PR), and DCR disease control rate was (CR+PR+SD). Patients were well follow-up after treatment.Results The overall response rate of chemotherapy for NSCLC was 32.4%. There was no significant difference in response rate between NSCLC patients with positive VEGF expression and patients with negative VEGF expression. The response rate in EGFR positive patients was significantly lower than patients with negative EGFR expression.Logistic regression analysis revealed that EGFR positive rate in squamous lung cancer was significantly higher than that in adenocarcinoma of lung, but the difference can’t influence the sensibility of chemotherapy. The response rate in EGFR positive patients was significantly lower than patients with negative EGFR expression. EGFR had an apparent effect on chemotherapy efficacy in NSCLC patients. (OR=0.474). EGFR can be used as a predictive index for prognosis and sensitivity of chemotherapy.Conclusion The chemotherapy plan can significantly influence the recovery and survival rate of a variety of tumors, including NSCLC. Some patients are not sensitive to certain chemotherapy regimens, and it is too late when we find it’s ineffective at the end of chemotherapy. The evaluation of sensitivity for chemotherapy before treatment is useful to find the sensitive ones and avoid unnecessary chemotherapy and treatment delay. Our study suggests that:EGFR could be used as an indicator of prognosis and sensitivity to chemotherapy. The detection of EGFR is useful for individualized treatment of lung cancer patients.

Related Dissertations

  1. The Clinical Research for the Effect of Iodine-125 Seeds Implanted in Advanced Bronchial Lung Cancer,R734.2
  2. The Expression of MMP-2、 VEGF and Ki-67 and Human Glioma Grade,R739.41
  3. Effects of 5-Aza-2-deoxycytidine on DNA Methylation and Expression of p16 and MGMT Gene in Lung Cancer Cell Line SPC-A-1,R734.2
  4. Study on the Expression and Correlation of Metallothionein and Matrix Metalloproteinase-2 in Non-small Cell Lung Cancer,R734.2
  5. The Research on Treatment of Lentivirus-mediated hVEGF-165 Gene Transferring Mesenchymal Stem Cells on Rat Hind Limb Ischemia,R329
  6. BMP2 and VEGF165 Genes Transfected Rat Bone Marrow Mesechymal Stem Cells Simultaneity Expression,R329
  7. The Molecular Biology of Rh-endostatin Plus Chemotherapy as Adjuvant Treatment for Non-small Lung Cancer,R734.2
  8. The Analysis of the Growth Factor Related with the Secondary Glaucoma in the Anterior Champer of Silicone Oil-filled Eyes,R779.6
  9. MMP-2, VEGF, CD105, Ki67 in small cell lung carcinoma and prognosis of,R734.2
  10. Experimental Studies on Therapy of Lung Cancer by VEGF-C siRNA Mediated by Liposomes,R734.2
  11. The Role and Mechanism of SDF-1/CXCR4 Axis in Small Cell Lung Cancer Invasion and Metastasis,R734.2
  12. The Effects of the VEGF Different Genotype Carriers on the Hypoxia Training to Acute Mountain Sickness,G804.2
  13. The Correlation between the Expression of NPRL2 Protein and Prognosis in Non-small Cell Lung Cancer,R734.2
  14. Rabbit skin inflamed by vaccinia virus extract injection on fracture healing and its molecular mechanism of experimental study,R965
  15. The Molecular Mechanism of OPN3 in Regulating the Resistance of Lung Cancer Cells to Paclitaxel,R734.2
  16. Methylation of p16 Gene in Plasma and Tissues from Non-small Cell Lung Cancer Patients, Demethylation and the Biological Behavior of Lung Cancer Cell and Transcription of p16 Gene,R734.2
  17. The Effect of Cisplatin on the Expression of Genes Involved in DNA Damage Response in Human Lung Cancer Cell Line LTEP-a-2,R734.2
  18. Avastin Eye Drops Inhibition of Corneal Neovascularization Experimental and Clinical Research,R772.21
  19. The Role and Possible Mechanism of Regulators of G-protein Signaling 5 in the Formation of Choroidal Neovascularization,R773.4
  20. Experimental Study on the Inhibition of Corneal Neovascularization with Bevacizumab and Their Ultrastructure,R772.2
  21. Ang-1 and VEGF Expression in Early Diabetic Retinopathy in Rats,R774.1

CLC: > Medicine, health > Oncology > Respiratory system tumors > Lung tumors
© 2012 www.DissertationTopic.Net  Mobile